Electromyographic Evaluation of the Efficacy of Manual Therapy in Temporomandibular Joint Dysfunction.
1 other identifier
interventional
34
1 country
1
Brief Summary
Individuals with temporomandibular joint dysfunction (TMD) may experience changes in muscle activation as a result of symptoms such as pain and limitation of movement. The aim of this study is to examine the efficacy of manual therapy electromyographically in patients with TMD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2021
CompletedFirst Submitted
Initial submission to the registry
June 13, 2022
CompletedFirst Posted
Study publicly available on registry
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2022
CompletedFebruary 21, 2023
February 1, 2023
1.2 years
June 13, 2022
February 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale (VAS)
A Visual Analogue Scale (VAS) is one of the pain rating scales used for the first time in 1921 by Hayes and Patterson. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
Change from initial assessment to 4 weeks after initial assessment.
Secondary Outcomes (6)
Electromyography (EMG)
Change from initial assessment to 4 weeks after initial assessment.
Pain Pressure Threshold (PPT)
Change from initial assessment to 4 weeks after initial assessment.
Maximum Mouth Opening (MMO)
Change from initial assessment to 4 weeks after initial assessment.
TAMPA
Change from initial assessment to 4 weeks after initial assessment.
Functional Limitation Scale of the Jaw-8
Change from initial assessment to 4 weeks after initial assessment.
- +1 more secondary outcomes
Study Arms (2)
Manual therapy
ACTIVE COMPARATORUpper cervical spine mobilization Posterior-anterior mobilization of the fifth cervical vertebra Suboccipital inhibition Suboccipital mobilization Trigger point application to my masseter, temporal and sternocleidomastoid muscles Intraoral and extraoral myofascial release Intraoral sphenopalatine ganglion technique TMJ mobilization Massage for chewing muscles The 45-minute treatment program, which includes applications including the techniques above, will be applied to the patients randomly assigned to the study group once a week for a total of 4 weeks.The changes in muscle activity of the masseter and anterior temporalis bilaterally will be recorded with EMG.
Control group
NO INTERVENTIONPatients assigned to the control group randomly will be re-evaluated 4 weeks after their initial evaluation. No intervention will be applied during this period. After 4 weeks, when the patients are re-evaluated, they will be directed to the appropriate treatment.
Interventions
Upper cervical spine mobilization Posterior-anterior mobilization of the fifth cervical vertebra Suboccipital inhibition Suboccipital mobilization Trigger point application to my masseter, temporal and sternocleidomastoid muscles Intraoral and extraoral myofascial release Intraoral sphenopalatine ganglion technique TMJ mobilization Massage for chewing muscles The 45-minute treatment program, which includes applications including the techniques above, will be applied to the patients randomly assigned to the study group once a week for a total of 4 weeks.The changes in muscle activity of the masseter and anterior temporalis bilaterally will be recorded with EMG.
Eligibility Criteria
You may qualify if:
- No cognitive impairment
- Diagnosed with temporomandibular joint(TMJ) dysfunction of myofascial origin,
- Volunteers aged 18-65
You may not qualify if:
- Malignancy and fracture of the cervical region and/or TMJ
- Active infection
- Patients actively receiving cervical and/or TMJ-related therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahçeşehir University
Istanbul, Europe, 34353, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kumru Ateş, PhC
Bahçeşehir University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD-C
Study Record Dates
First Submitted
June 13, 2022
First Posted
June 15, 2022
Study Start
June 10, 2021
Primary Completion
September 5, 2022
Study Completion
November 10, 2022
Last Updated
February 21, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share